News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
420,578 Results
Type
Article (23745)
Company Profile (79)
Press Release (396753)
Multimedia
Podcasts (98)
Webinars (15)
Section
Business (140754)
Career Advice (1084)
Deals (23023)
Drug Delivery (124)
Drug Development (51991)
Employer Resources (85)
FDA (9622)
Job Trends (9092)
News (210181)
Policy (19588)
Tag
2027 BioCapital Standard (4)
2027 BioMidwest Digital (1)
2027 BioMidwest Elite (1)
2027 BioMidwest Standard (2)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Digital (1)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (4)
2027 Genetown Premier (1)
2027 Genetown Standard (3)
2027 Pharm Country Digital (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (8)
40 Under 40 (1)
Academia (1422)
Academic (1)
Accelerated approval (43)
ADA (18)
Adcomms (10)
Allergies (143)
Alliances (33686)
ALS (155)
Alzheimer's disease (1100)
Antibody-drug conjugate (ADC) (459)
Approvals (10310)
Artificial intelligence (604)
ASCO (186)
Autoimmune disease (275)
Automation (45)
Bankruptcy (181)
Belgium (8)
Best Places to Work (6826)
BIO (38)
Biologics (54)
BIOSECURE Act (10)
Biosimilars (235)
BioSpace Insights (116)
Biotechnology (41)
Bispecific (28)
Bladder cancer (124)
Brain cancer (67)
Breast cancer (475)
Cancer (4114)
Cardiovascular disease (377)
Career advice (967)
Career pathing (38)
CAR-T (177)
CDC (21)
CDMO (133)
Celiac Disease (1)
Cell-line development (1)
Cell therapy (536)
Cervical cancer (39)
Clinical research (46288)
Collaboration (1848)
Commercialization (41)
Company closure (5)
Compensation (522)
Complete response letters (63)
COVID-19 (2289)
CRISPR (96)
CRO (2)
C-suite (1111)
Cystic fibrosis (118)
Data (5764)
Decentralized trials (2)
Denatured (37)
Depression (118)
Dermatology (113)
Diabetes (332)
Diagnostics (3743)
Digital health (36)
Diversity (8)
Diversity, equity & inclusion (23)
Drug discovery (340)
Drug pricing (144)
Drug shortages (17)
Duchenne muscular dystrophy (182)
Earnings (46092)
Editorial (34)
Employer branding (8)
Employer resources (84)
ESMO (241)
Events (60229)
Executive appointments (932)
Eye disease (7)
FDA (12470)
Fibrodysplasia Ossificans Progressiva (13)
Fragile X (5)
Friedreich's ataxia (7)
Frontotemporal dementia (22)
Funding (1418)
Gene editing (174)
Generative AI (56)
Gene therapy (411)
GLP-1 (705)
Government (2449)
Grass and pollen (7)
Guidances (253)
Healthcare (8334)
Hematology (114)
HIV (59)
Huntington's disease (34)
Idiopathic pulmonary fibrosis (8)
IgA nephropathy (109)
Immunology and inflammation (179)
Immuno-oncology (87)
Indications (196)
Infectious disease (2502)
Inflammatory bowel disease (159)
Inflation Reduction Act (10)
Influenza (84)
Intellectual property (242)
Interviews (177)
IPO (10155)
IRA (39)
Job creations (2497)
Job search strategy (788)
JPM (35)
Kidney cancer (23)
Kidney disease (93)
Labor market (67)
Layoffs (298)
Leadership (37)
Legal (4597)
Licensing (75)
Liver cancer (65)
Longevity (34)
Lung cancer (596)
Lung diease (8)
Lymphoma (326)
Machine learning (40)
Management (34)
Manufacturing (994)
Marketing (19)
MASH (143)
Medical affairs (3)
Medical device (5337)
Medtech (5442)
Mergers & acquisitions (13899)
Metabolic disorders (965)
mRNA (180)
Multiple sclerosis (117)
Multispecific (4)
NASH (15)
Netherlands (20)
Neurodegenerative disease (287)
Neuropsychiatric disorders (80)
Neuroscience (2214)
Neurotech (3)
NextGen: Class of 2026 (3007)
Non-profit (1743)
Now hiring (31)
Obesity (471)
Opinion (215)
Ovarian cancer (130)
Pain (217)
Pancreatic cancer (202)
Parkinson's disease (264)
Partnered (22)
Patents (495)
Patient advocacy (3)
Patient recruitment (478)
Patient selection (55)
Peanut (30)
People (41306)
Peptides (21)
Pharmaceutical (38)
Pharmacy benefit managers (23)
Phase 1 (12803)
Phase 2 (19757)
Phase 3 (17112)
Pipeline (7992)
Policy (197)
Postmarket research (1756)
Preclinical (5409)
Press Release (61)
Prostate cancer (225)
Psychedelics (45)
Radioligand (1)
Radiopharmaceuticals (249)
Rare diseases (852)
Real estate (3613)
Recruiting (34)
Regenerative medicine (16)
Regulatory (16601)
Reports (30)
Research institute (1387)
Resumes & cover letters (129)
Rett syndrome (23)
RNA editing (20)
RSV (46)
Schizophrenia (134)
Series A (286)
Series B (209)
Service/supplier (3)
Sickle cell disease (83)
Special edition (16)
Spinal muscular atrophy (103)
Sponsored (29)
Startups (2653)
State (2)
Stem cells (6)
Stomach cancer (12)
Substance use disorders (12)
Supply chain (97)
Switzerland (6)
Tariffs (75)
The Weekly (59)
Vaccines (723)
Venture capital (94)
Weight loss (253)
Wet AMD (5)
Women's health (121)
Worklife (19)
Date
Last 7 days (444)
Last 30 days (1556)
Last 365 days (17309)
2026 (14559)
2025 (16995)
2024 (19717)
2023 (22830)
2022 (31664)
2021 (33768)
2020 (32383)
2019 (24645)
2018 (18979)
2017 (20016)
2016 (18976)
2015 (22244)
2014 (17441)
2013 (14537)
2012 (15480)
2011 (16125)
2010 (14430)
Location
Africa (486)
Alabama (57)
Alaska (4)
Arizona (147)
Arkansas (9)
Asia (38377)
Australia (5067)
California (8102)
Canada (2830)
China (1495)
Colorado (392)
Connecticut (342)
Delaware (313)
Europe (63309)
Florida (1308)
Georgia (155)
Hawaii (3)
Idaho (30)
Illinois (753)
India (133)
Indiana (434)
Iowa (14)
Japan (746)
Kansas (101)
Kentucky (29)
Louisiana (19)
Maine (19)
Maryland (927)
Massachusetts (6186)
Michigan (96)
Minnesota (404)
Mississippi (6)
Missouri (62)
Montana (14)
Nebraska (11)
Nevada (65)
New Hampshire (30)
New Jersey (2831)
New Mexico (15)
New York (2278)
North Carolina (1119)
North Dakota (7)
Northern California (4142)
Ohio (207)
Oklahoma (14)
Oregon (32)
Pennsylvania (1614)
Puerto Rico (26)
Rhode Island (32)
South America (710)
South Carolina (22)
South Dakota (1)
Southern California (3327)
Tennessee (119)
Texas (1120)
United States (29542)
Utah (217)
Vermont (2)
Virginia (299)
Washington D.C. (53)
Washington State (675)
West Virginia (2)
Wisconsin (106)
Wyoming (5)
420,578 Results for "chugai pharmaceutical co ltd japan".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
TME Pharma Signs Binding Exclusive Negotiation Agreement with Japanese TMS Co., Ltd.
October 29, 2026
·
7 min read
Press Releases
Three Chugai Researchers Behind the Discovery of Hemlibra for Hemophilia A Receive Prestigious U.S. Lasker Award, One of the World’s Most Respected Scientific Honors
September 9, 2026
·
16 min read
Press Releases
Kiora Pharmaceuticals In-Licenses Late-Stage, Oral Neuroprotective Calpain Inhibitor for Central Retinal Artery Occlusion (CRAO) with Planned Expansion into NAION; Asset Completed Phase 3 Clinical Trial in CRAO in Japan
• The oral small-molecule calpain inhibitor demonstrated meaningful visual acuity improvement in Phase 2 and Phase 3 CRAO studies conducted in Japan compared to controls. • No therapeutics exist today to treat patients that experience CRAO vision loss. • Kiora plans to advance KIO-401 (mitucapistat) into a multinational Phase 3 registration trial in CRAO, with initiation targeted for 2027. • Company also plans to evaluate KIO-401 in a Phase 2b clinical trial in non-arteritic anterior ischemic optic neuropathy (“NAION”).
October 29, 2026
·
10 min read
Press Releases
Taiwan-Based Towards Buddha Co., Ltd. Showcases Medical-Grade TPU Tubing Injection Solutions at Medtec Japan 2026
April 9, 2026
·
2 min read
Obesity
Roche cuts muscle-sparing obesity drug after mid-stage disappointment
Roche’s anti-myostatin therapy emugrobart is unlikely to elicit meaningful weight loss, according to an interim mid-stage analysis, prompting the pharma to return the asset rights to its subsidiary Chugai Pharmaceutical.
September 29, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Visionary Holdings’ Subsidiary Nanjing Tuoyuanjian Health Technology Co., Ltd. Enters into Distribution Agreement with Suncare (Shanghai) Health Technology Co., Ltd.
Collaboration Expected to Expand the Commercialization of Stem Cell Aesthetic and Anti-Aging Products Through an AI-Enabled Community Healthcare and Senior Care Network in China
July 29, 2026
·
4 min read
Press Releases
ADC Therapeutics Announces ZYNLONTA® Updates in Japan
October 29, 2026
·
8 min read
Press Releases
FreeMind Investments and Daewoong Pharmaceutical Co., Ltd. Invest in General Proximity
May 4, 2026
·
4 min read
Press Releases
JCR Pharmaceuticals Receives Orphan Drug Designation from the Ministry of Health, Labour and Welfare of Japan for Givinostat for Duchenne Muscular Dystrophy
September 28, 2026
·
8 min read
Press Releases
Rhythm Pharmaceuticals Announces Commercial Launch of IMCIVREE® (setmelanotide) in Japan for Patients with Acquired Hypothalamic Obesity
October 14, 2026
·
9 min read
1 of 42,058
Next
